SB
PCRX icon

Suntrust Banks’s Pacira BioSciences PCRX Stock Holding History

Suntrust Banks’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-14,328
Closed -$684K – 1305
2017
Q2 		$684K Sell
14,328
-109
-0.8% -$5.06K ﹤0.01% 755
2017
Q1 		$658K Buy
14,437
+2,385
+20% +$103K ﹤0.01% 761
2016
Q4 		$388K Sell
12,052
-91
-0.7% -$3.04K ﹤0.01% 1121
2016
Q3 		$415K Sell
12,143
-7,037
-37% -$276K ﹤0.01% 1039
2016
Q2 		$646K Buy
19,180
+13,448
+235% +$661K ﹤0.01% 856
2016
Q1 		$303K Buy
+5,732
New +$335K ﹤0.01% 1127
2014
Q2 		– Sell
-20,850
Closed -$1.46M – 1612
2014
Q1 		$1.46M Buy
+20,850
New +$1.42M 0.01% 785

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

Suntrust Banks's PCRX Position: Q3 2017 in Review

Suntrust Banks sold out of Pacira BioSciences (PCRX) in Q3 2017, closing a stake of 14,328 shares — an estimated $684K sold.

Suntrust Banks first reported a position in PCRX in Q1 2014 and held it in 7 quarters. The position peaked at $1.46M in Q1 2014. 180 funds tracked by Wall St. Rank hold PCRX as of Q3 2017.

  • Suntrust Banks reported no remaining Pacira BioSciences position as of Q3 2017 after selling out during the quarter.
  • Suntrust Banks sold 14,328 Pacira BioSciences shares in Q3 2017, an estimated $684K.
  • Suntrust Banks first reported a position in Pacira BioSciences in Q1 2014 and held it in 7 quarters.
  • Suntrust Banks's Pacira BioSciences position peaked at $1.46M in Q1 2014.
  • 180 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2017.

Based on Suntrust Banks's 13F filing for Q3 2017, filed 14 Nov 2017.